Legal opinion of Tianyuan Law Firm on the 2023 annual shareholders' meeting, 2024 second A-share category shareholder meeting and 2024 second listed in Hong Kong category shareholder meeting of Joinn Laboratories.
Announcement of resolutions of 2023 annual general meeting of shareholders, 2024 second A-share category shareholders' meeting and 2024 second H-share category shareholders' meeting of Joinn Laboratories.
Information on the 2023 Annual General Meeting of Shareholders of Zhaoyan Pharmaceutical, the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024
Notice of Zhaoyan Pharmaceutical on holding the 2023 Annual General Meeting of Shareholders, the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024
Announcement of Zhaoyan Pharmaceutical's response to the Shanghai Stock Exchange's letter on the information disclosure supervision of the company's 2023 annual report
Zhaoyan Pharmaceutical's progress announcement on cooperation with professional investment institutions to participate in the establishment of industrial funds and related transactions
Zhaoyan Pharmaceutical's progress announcement on cooperation with professional investment institutions to participate in the establishment of industrial funds and related transactions
Announcement of Zhaoyan Pharmaceutical on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for the repurchase of A-shares
Working Rules for the Audit Committee of the Board of Directors of Beijing Zhaoyan New Drug Research Center Co., Ltd. (March 2024)
Working Rules of the Nomination Committee of the Board of Directors of Beijing Zhaoyan New Drug Research Center Co., Ltd. (March 2024)
Zhaoyan New Pharmaceutical 2023 Financial Results Report
Working Rules of the Remuneration and Assessment Committee of the Board of Directors of Beijing Zhaoyan New Drug Research Center Co., Ltd. (March 2024)
Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd. Foreign Investment Management System (March 2024)
Special Report on Zhaoyan Pharmaceutical's 2023 Non-Operating Capital Occupation and Other Related Capital Transactions
Beijing Zhaoyan New Drug Research Center Co., Ltd. 2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee of the Board of Directors of Beijing Zhaoyan New Drug Research Center Co., Ltd. in 2023
Report of the Audit Committee of the Board of Directors of Zhaoyan New Pharmaceutical on the performance of supervisory duties by accounting firms in 2023
Announcement of Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd. on changing the registered capital of the company and amending the company's articles of association
Announcement of Resolutions of Zhaoyan Pharmaceutical's 2024 First Extraordinary General Meeting of Shareholders, 2024 First Class A Shareholders' Meeting, and 2024 First Class H Shareholders' Meeting
Legal opinions of Beijing Tianyuan Law Firm on Zhaoyan New Pharmaceutical's 2024 First Extraordinary General Meeting of Shareholders, 2024 First Class A Shareholders' Meeting, and 2024 First Class H Shareholders' Meeting
No Data